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Abstract
Objectives: We recommend a new kind of  spray made from eight kinds of  traditional Chinese medicine, we aimed to investigate 
the safety and clinical efficacy of  combined traditional Chinese medicine spray (TCMS) with premature ejaculation desensitiza-
tion therapy (PEDT) for the treatment of  primary premature ejaculation (PPE).
Methods: A total of  90 patients with PPE were randomly assigned to receive TCMS, PEDT monotherapy or TCMS plus PEDT 
combination therapy for 6 weeks. Intravaginal ejaculation latency time (IELT) and Chinese index of  sexual function for prema-
ture ejaculation (CIPE-5) were measured to evaluate the effect of  each treatment.
Results: Eighty six (86) participants completed the study voluntarily. Both IELT and CIPE-5 in these three groups increased 
after treatment when compared with baseline levels (p< 0.01). IELT and CIPE-5 after treatment in TCMS plus PEDT group 
were significantly higher than those in the other two groups (both p <0.05). Additionally, clinical efficacy in TCMS plus PEDT 
group (89.7%) was significantly higher than in TCMS (65.5%) and PEDT group (67.9%) (p< 0.01).
Conclusion: The self-made TCMS was safe and effective for the treatment of  PPE, a combination of  TCMS and PEDT ther-
apy was more effective than the TCMS or PEDT monotherapy.
Keywords: Primary premature ejaculation (PPE); traditional Chinese mdicine spray (TCMS); premature ejaculation desensiti-
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Premature ejaculation (PE) is a very common male sex-
ual dysfunction with prevalence rates of  20–30%1,2. As 
people's awareness on sexual attitudes changes, more at-
tention has been paid to the impact on quality of  life for 
patients and their sexual partners with PE. Both the pa-
tients and their partners complain about decreased sexual 
self-confidence and self-esteem and an overall reduction 
in their quality of  life3.
PE is classified as primary (lifelong) or secondary (ac-
quired) if  it is present at almost every intercourse from 
the first sexual encounter on wards. While the pathophys-
iology of  primary premature ejaculation (PPE) is not 
fully understood, nowadays it is clear that both organic 
and psychosocial factors play a role in the etiology4, glans 
penile hypersensitivity and hyperexcitability is the gen-
eral reason for PPE5-7. Studies found that patients with 
PPE have more dorsal nerves of  the penis than healthy 
adults, this abnormal distribution of  dorsal nerves pos-
sibly leads to glans penile hypersensitivity, lowering the 
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threshold value as well as shortening the ejaculation la-
tency time8. They also generally have other abnormal 
autonomic reflex pathways for the ejaculatory process, 
including shorter bulbocavernosal latency time and high-
erbulbocavernosal evoked potentials6,9,10. Thus therapy of  
reducing glans penile hypersensitivity should be effective 
for the treatment of  PPE.
Herbs have long been used in the traditional Chinese and 
Indian systems of  medicine for the treatment of  sexual 
dysfunction in men11,12. Many kinds of  herbs have the ef-
fect of  local anesthesia, vaso-activation and so on. Radix 
Aconiti (Chuanwu) was used for the treatment of  a “pe-
ripheral uncomfortable feeling of  cold” in Japan13, its ac-
tive ingredients could affect peripheral vascular function 
via the nitric oxide (NO) system14. Studies showed that 
nitric oxide (NO) might be a neurotransmitter involved 
in the central and peripheral control of  ejaculation15,16. 
Herba Asari (Xixin) is a traditional herb medicine used 
as remedies for aphthous stomatitis, toothache, gingivitis 
and as a local anesthetic agent in Korea and China17. Peri-
carpium Zanthoxyli (Chuanjiao) is a kind of  medicinal and 
edible herb, the component of  volatile oil has a strong ef-
fect of  local anesthesia18. Syzygium aromaticum (Dingxiang) 
is not only used in China to treat male sexual dysfunction, 
but also used in India as an aphrodisiac to treat erectile 
dysfunction, the active ingredients may have ROCK-II 
inhibitory potential which can result in relax of  corpus 
cavernosum, thus it is effective for sexual dysfunction12. 
Some of  the above traditional herbs have been stud-
ied for the treatment of  PE, others have not, we united 
eight kinds of  traditional Chinese medicine (4 mentioned 
above, other 4 not mentioned) according to traditional 
Chinese medicine theory, and we aimed to evaluate the 
safety and clinical efficacy of  the ethanol extract from the 
eight kinds of  medicine for the treatment of  PPE.
Because PE involves both psychosocial and physiolog-
ic determinants, a combination psychosocial and phar-
macologic therapy may be the best choice to optimize 
efficacy and minimize relapse19,20. Behavioral therapy is 
the main content of  psychosocial treatment. Behavioral 
strategies mainly include the ‘‘stop-start programme de-
veloped by Semans21, and its modification, the ‘‘squeeze’’ 
technique, proposed by Masters and Johnson22 (several 
modifications exist), however, it needs the partner’s coop-
eration for a long time and its difficult on a large degree23. 
Domestic scholars reported that Weili Multifunctional 
Andrologic Disease Diagnosis And Treatment worksta-
tion (WLZZ-9999, made by weili new century science & 
tech. Co. Ltd, Beijing, China) can obtain a good effect 
of  treatment for PE with desensitization training thera-
py24. The automated machine can help patients complete 
the behavioral therapy instead of  the patients and their 
partners themselves. The course of  the treatment is as 
follows: first, the machine gives a small stimulation to the 
patient’s penis to the point just before ejaculation, and 
then stops. Once the sensation has subsided, then starts 
again. When the patient develops relatively longer time 
of  ejaculation control, stronger intensity of  stimulation is 
given to the penis gradually, then the above treatment is 
repeated. Generally, treatment is given 3 times a week, six 
times as a course of  treatment.
In summary, traditional medicine has long been used to 
treat sexual dysfunction in many countries in Asia and 
should be fully exploited. In this study, we united eight 
kinds of  traditional Chinese medicine together and made 
them into a spray, and explored the safety and clinical ef-
ficacy of  this traditional Chinese medicine spray (TCMS) 
and combined TCMS with premature ejaculation desensi-




A total of  90 heterosexual men complaining of  PPE were 
recruited from the out-patient clinic of  Enshi Tujia and 
Miao Autonomous Prefecture nationality Hospital De-
partment of  Urology, Enshi, China, from April 2012 to 
April 2013. After completing description of  the study to 
the volunteers, the written informed consent including 
necessary details of  the study was obtained from each 
patient. The study protocol was approved by the Ethics 
Committee of  Enshi Tujia and Miao Autonomous Pre-
fecture central Hospital. The enrolled men aged 21–38 
years had been in a stable, monogamous, heterosexual 
relationship with regular sexual intercourse at least twice 
per week with a cooperative female partner. All male pa-
tients were asked to avoid condom use. Demographic 
data of  all the patients were recorded. The study was per-
formed for 6 weeks.
Inclusion criteria
All the patients were diagnosed according to The Diag-
nostic and Statistical Manual of  Mental Disorders, Fourth 
Edition criteria of  PE25, the condition’s onset is from the 
first sexual experience and remains a problem through-
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out life, IELT was shorter than 2 min, CIPE-5 was lower 
than 18 scores; older than 18 years, external genitalia was 
normally developed, no phimosis, no obvious prepuce, 
and normal erectile function; receiving clinical observa-
tion and completing the trial voluntarily; blood testoster-
one (T), follicle stimulating hormone (FSH), luteinizing 
hormone (LH),  prolactin (PRL) and estradiol (E2) were 
normal.
Exclusion criteria
Exclusion criteria included patients with secondary PE; 
sexual dysfunction (decreased sexual interest, erectile dys-
function, painful intercourse, urinary tract infection, or 
female sexual dysfunction that affected the sexual rela-
tionship); those suffering from prostatitis; history of  a 
psychiatric or neurological disorder; abuse (alcohol or 
drug); previous genitourinary system trauma or surgery; 
spinal cord injury; or currently taking a drug known to 
affect sexual function, including either topical penile ap-
plications or systemic drugs.
Study design
All of  the 90 patients were randomly divided through 
a simple (complete) randomization process into three 
groups, each consisting of  30 patients. Patients in TCMS 
group were given TCMS only. The TCMS was made by 
the hospital pharmacy department and consisted of  eight 
kinds of  traditional Chinese medicine. The manufacture 
method was as follows: 30 g of  Herba Asari, 30 g of  Syz-
ygium aromaticum, 20 g of  Ootheca Mantidis, 20 g of  Radix 
Aconiti, 20 g of  Galla Chinensi, 20 g of   Fructus Rosae Lae-
vigatae, 20 g of  Fructus Rubi, 1 g of  Pericarpium Zanthoxyli 
were accurately weighed and soaked in 100 milliliter of  
alcohol (concentration 95%) for 30 days, then transferred 
the supernatant to the watering can for standby use. (dry 
weight ratio of  each medicine was showed in table 1). Pa-
tients were guided to spray the TCMS evenly on the glans 
penis surface, coronary sulcus, foreskin frenum and the 
surrounding area once a day. It should also been applied 
to the glans penis 30 min before intercourse and washed 
off  immediately prior to coitus. Patients in PEDT group 
were given PEDT by the use of  Weili Multifunctional 
Andrologic Disease Diagnosis And Treatment worksta-
tion (WLZZ-9999), 3 times a week. Patients in TCMS 
plus PEDT group were given combined TCMS (once a 
day, as well as before sexual intercourse) with PEDT (3 
times a week). All of  the patients were asked not to use 
other therapies during the 6-week treatment period.
Measurements
IELT
The duration of  IELT is the time from penetration (vag-
inal penetration) until ejaculation (release of  semen) and 
was timed on a stopwatch by ‘start’ (penetration) to ‘stop’ 
(ejaculation). Either of  the partners was allowed to han-
dle the stopwatch; however, it was requested that the 
same person remain responsible for every IELT measure-
ment for the duration of  the study, and they were asked 
to be honest in recording the time. They were instructed 
to calculate and record the exact time after ejaculation. 
The IELT was recorded before and 6 weeks after the 
treatment.
CIPE-5
CIPE-5 contains 5 questionnaires: IELT; difficulty in 
prolonging sexual intercourse; sexual satisfaction; part-
ner’s sexual satisfaction; frequency of  feeling anxious, 
depressed or stressed in sexual activity. Each of  the ques-
tions was designed to be answered by the subject on a 5 
point Likert - type scale, generating each item scores as a 
total score. If  the IELT of  the patient was more than 3 
minutes, the score of  IELT was 5 point. The CIPE-5 was 
recorded before and 6 weeks after the treatment.
Clinical efficacy
Clinical efficacy was compared with the prolongation of  
IELT and elevation of  CIPE-5 scores before and after 
each treatment. If  the prolongation of  IELT was more 
than 2 minutes as well as the elevation of  CIPE-5 was 
higher than 18 scores, the trial was considered effective, 
on the contrary, the trial was considered invalid. Efficacy 
rate was calculated in each group.
Statistical analysis
Descriptive data were presented as mean± SD (stan-
dard deviation). 
Demographic data, IELT, CIPE levels among each group 
were compared using Kruskal-Wallis test, comparisons 
before and after treatment in each group were also per-
formed using Kruskal-Wallis test, due to skewness in the 
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distributions of  some of  these measurements. Efficacy 
rate among each groups were compared with chi-square 
test. All statistical analysis was performed using the spss 
17.0 software. P<0.05 was considered statistically signif-
icant.
Results
Demographic data, IELT and CIPE-5 baseline.
Of  all the 90 enrolled patients, 4 withdrew from the study 
(1 from TCMS group, 2 from PEDT group and 1 from 
combination group). So a total of  86 patients completed 
the study voluntarily (Figure 1). 
Figure 1. Flow chart of  the study.
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No statistically significant difference was found among the 3 groups with regard to demographic data, IELT and 
CIPE-5 baseline, shown in table 2.
 
Table 1. The dry weight ratio of herbal medicine in the spray. 
Chinese name Pharmaceutical name （medical parts） Ratio 
Xixin  Herba Asari (Dried root of Herba Asari) 30 
Dingxiang Syzygium aromaticum (Dried flower bud of Syzygium aromaticum) 30 
Chuanwu  Radix Aconiti (Dried root of Radix Aconiti) 20 
Wubeizi  Galla Chinensis (Dred fruit of Galla Chinensis) 20 
Jinyingzi  Fructus Rosae Laevigatae (Dred fruit of Fructus Rosae Laevigatae) 20 
Fupenzi  Fructus Rubi (Dred fruit of Fructus Rubi) 20 
Sangpiaoxiao Ootheca Mantidis (Dried Ootheca of mantis) 20 
Chuanjiao  Pericarpium Zanthoxyli (Dred fruit of Pericarpium Zanthoxyli) 1 
Net weight 161 g of herbal medicine was extracted with 100 ml (95%) alcohol for 30 days, then 
filtrated for standby use. 
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IELT, CIPE-5 change from baseline to the end of  
treatment.
IELT increased significantly from 1.15 min to 2.99 min 
in TCMS group (p< 0.01); from 1.16 min to 3.14 min in 
PEDT group (p< 0.01) and from 1.13 min to 4.36 min 
in TCMS plus PEDT group (p< 0.01). CIPE-5 scores 
elevated from 9.93 to 19.69 in TCMS group (p< 0.01), 
from 10.36 to 20.11 in PEDT group (p< 0.01) and from 
10.03 to 23.14 in TCMS plus PEDT group (p< 0.01). 
Both TCMS and CIPE-5 in TCMS plus PEDT group af-
ter treatment was significantly higher than in TCMS (both 
p< 0.05) and PEDT group (both p< 0.05). (table 3)






TCMS plus PEDT 
(n=29) 
P-value 
Demographic characteristics         
Age(year) 28.4 ( 3.8) 27.9 ( 3.3) 28.6 ( 3.9) 0.79 
Height(cm) 171.6 ( 5.9) 172.5 ( 5.5) 171.3 ( 5.4) 0.70 
Weight(kg) 67.0 ( 6.8) 66.3 ( 7.3) 66.5 ( 7.4) 0.93 
BMI(kg/m2) 22.7 ( 1.6) 22.2 ( 1.6) 22.6 ( 1.6) 0.48 
Course of disease(year) 4.5 ( 2.9)  4.3 ( 2.8) 4.6 ( 3.0) 0.93 
Baseline (pre-treatment)         
IELT (min) 1.15( 0.36) 1.16 ( 0.31) 1.13 ( 0.27) 0.87 
CIPE-5 (score) 9.93 ( 2.98) 10.36 ( 3.09) 10.03 ( 2.98) 0.60 
BMI: Body mass index; 
IELT: Intravaginal ejaculation latency time; 
CIPE-5: Chinese index of sexual function for premature ejaculation 
Kruskal–Wallis analysis of variance was used to compare the median among each group. 
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Efficacy
When the criteria of  clinical efficacy was defined as the 
IELT ≥ 2 min and the CIPE-5 ≥18 scores after treat-
ment, the number of  eligible patients was 19, 19 and 26 in 
TCMS, PEDT and combination group, respectively. The 
efficacy in combination group (89.7%) was significant-
ly higher than that in TCMS group (65.5%) and PEDT 
group (67.9%) (both p< 0.01), no significant difference 
existed between TCMS and PEDT group, as shown in 
figure 2.
Figure 2. Clinical efficacy rate in each group. * Compared with TCMS group (p< 0.05); #compared 
with PEDTgroup (p< 0.05); No significant difference exists between TCMS and PEDT group
Table 3. IELT and CIPE-5 levels before and after treatment in each group (Mean±SD). 
 
Outcome Variable TCMS PEDT TCMS plus PEDT P a 
IELT (min)         
   Baseline 1.15 ( 0.36) 1.16 ( 0.31) 1.13 ( 0.27) 0.87 
   End point 2.99 (1.40) 3.14 (1.23) 4.36 (1.31)*# < 0.01 
   Pb < 0.01 < 0.01 < 0.01   
CIPE-5 (score)         
   Baseline 9.93( 2.98) 10.36( 3.09) 10.03( 2.98) 0.60 
   End point 19.69(3.93) 20.11(3.83) 23.14(2.64)*# < 0.01 
   P b < 0.01 < 0.01 < 0.01   
a Kruskal–Wallis test was used to compare the median among each group. 
bKruskal–Wallis test was used to compare the median between the levels before and after treatment. 
*p< 0.05 when compared with TCMS group. 
#p<0.05 when compared with PEDT group 
Abbreviations as in Table 2. 
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Side effects in each group.
Throughout the study, no serious systemic or local side 
effect occurred except that slight burning sensation pre-
sented by part of  the patients, but this slight discomfort 
was tolerable.
Discussion
PE is the most frequent male sexual dysfunction with 
a serious effect on the quality of  life for both the pa-
tient and partner20,26. In this study, we employed IELT 
as the main measure for comparing different treatment 
options as it is the most universally accepted tool. Data 
from previous studies indicated that IELT measurement 
alone is not sufficient for accurately determining the PE 
status27,28, so another useful index CIPE-5 was employed 
for the evaluation of  ejaculation control, sexual satisfac-
tion of  patients and partners, as well as personal distress. 
Employing a cutoff  score of  18, the sensitivity of  CIPE-
5 was 97.60%, the specificity 94.74%29.
This present study showed that both IELT and CIPE-5 
significantly increased in the three groups, whereas the 
increase in TCMS plus PEDT group was more than that 
in other two groups (Table 3). Additionally, clinical effi-
cacy rate in TCMS plus PEDT group (89.7%) was also 
significantly higher than that in TCMS group (65.5%) and 
PEDT group (67.9%) (Figure 2). The results demonstrat-
ed that a combination of  TCMS and PEDT therapy was 
more efficient for the treatment of  PPE than TCMS or 
PEDT monotherapy.
All the patients were satisfied with their tolerance to the 
treatment in each group, no side effect was reported by 
the subjects in each group during the treatment course. 
It is worth mentioning that the combination therapy as 
well as the single TCMS therapy should not be used for 
the patients allergic to alcohol. Present therapies for the 
treatment of  PE mainly include systemic pharmacologi-
cal agents, topical agents and behavioral therapy, none of  
them seems to be ideal. Systemic pharmacological agents 
like selective serotonin reuptake inhibitors (SSRIs) and 
phosphodiesterase-5 (PDE-5) inhibitors all have systemic 
side effects, such as dry mouth, nausea, decreased libido, 
erectile dysfunction and so on30. Topical agents includ-
ing severance secret-cream(SS-cream), dyclonine/alpros-
tadil cream, lidocaine spray, prilocaine-lidocaine spray, 
all of  them can reduce the sensitivity of  the glans penis 
meanwhile the side effect cannot be ignored. The most 
common side effects of  these agents’ use are associated 
with localized irritation, including pain, burning, delayed 
ejaculation, loss of  penile sensation21,31,32, wiping off  be-
fore intercourse or condom use is necessary to avoid the 
side effect of  decreased vaginal sensitivity of  the part-
ners. However, in our study, no serious systemic or local 
side effect occurred except that slight burning sensation 
presented on part of  patients, but this slight discomfort 
was tolerable. Therefore, we believed that the self-made 
TCMS was safe and could obtain a good compliance.
Traditional herbs have long been used for the treatment 
of  PE in China, India and several other countries. From 
the traditional Chinese medicine point of  view, kidney 
yang failure is one of  the main reasons for premature 
ejaculation, therefore the herbs with hot property such 
as Radix Aconiti, Herba Asari, Syzygium aromaticum and Peri-
carpium Zanthoxyli were selected to warm the kidney yang. 
Ootheca Mantidis, Galla Chinensis, Fructus Rosae Laevigatae 
and Fructus Rubi have the property of  convergence, so 
we used them to prevent premature ejaculation. Modern 
researches show that Radix Aconiti has a wide range of  
therapeutic effects, active components are alkaloids such 
as aconitine, these alkaloids have pain-relieving effects, 
cardiotonic and vasodilator actions14,33,34, the vasodilator 
action may be induced by the increased yield of  nitric 
oxide14, the latter has been detected as a neurotransmitter 
involved in the central and peripheral control of  ejacu-
lation, so Radix Aconiti may inhibit seminal emission by 
increasing the production of  nitric oxide. 
Herba Asari is rich in volatile oils, as the characteristic 
components, methyl eugenol and safrole may have local 
anesthetic and analgesic effects35. Studies show that Peri-
carpium Zanthoxyli has an obvious effect of  local anesthe-
sia and the main active ingredient is amide compounds, 
volatile oil. Water soluble matter of  Pericarpium Zanthoxyli 
can reversibly block nerve impulse conduction and low-
er neural stem excitability of  toad sciatic nerve, this may 
be the physiological basis of  local anesthesia induced by 
Pericarpium Zanthoxyli36. Syzygium aromaticum has long been 
used in China and India to treat male sexual dysfunction, 
animal experiments showed that low dose of  Syzygium 
aromaticum might have androgenic effect which could in-
crease the motility of  sperm and stimulate the secretory 
activities of  epididymis and seminal vesicle37. The active 
ingredients of  Syzygium aromaticum may also have ROCK-
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II inhibitory potential which could result in relaxation of  
corpus cavernosum, thus it has an effect on sexual dys-
function12. Galla Chinensis is rich in tannic acid which can 
lead to protein precipitation38. Galla Chinensis may treat 
PE through thickening skin and mucous membranes of  
the glans thus reducing its sensitivity.
Overall, the referring herbs may treat PE from different 
angles, both Radix Herba Asari and Pericarpium Zanthoxy-
li have local anesthesia effect, Galla Chinensis can lead to 
proteins precipitation, so they may treat PE by reducing 
the sensitivity of  glans. Radix Aconiti has vasodilator ac-
tion and Syzygium aromaticum can inhibit corpus caverno-
sum relax so as to promote penis hyperemia, Radix Aconiti 
may also inhibit the function of  the sympathetic nervous 
system activity through increased NO and then inhibit 
ejaculation. Syzygium aromaticum may have androgenic ef-
fect. These herbs may play a role of  superposition for 
the treatment of  PE. There were also other desensitising 
agents which were promising for the treatment of  PE. 
Dinsmore et al39 carried out a phase III, double-blind, 
placebo-controlled study and showed that PSD502 (three 
actuations of  spray each containing 7.5 mg lidocaine and 
2.5 mg prilocaine) improved ejaculatory latency, control 
and sexual satisfaction when applied topically 5 min be-
fore intercourse in men with PE. IELT in that study in-
creased by 6.3-fold of  baseline level after 3-month treat-
ment.  In another two double-blind, placebo-controlled, 
phase III study carried out by Carson et al40, PSD502 ap-
plied topically to the glans penis 5 minutes before inter-
course also showed significantly improved ejaculatory la-
tency, ejaculatory control, sexual satisfaction and distress, 
and no severe side effects occurred. The baseline levels 
of  IELT in our study was much higher than that in the 
above studies, and the fold of  increase for IELT was also 
different, this may be due to the duration of  treatment 
and also the dose of  treatment. Both the two therapies 
were promising for clinical use since they were effective 
and safe.
In this study, we used PEDT therapy supported by Wei-
li Multifunctional Andrologic Disease Diagnosis And 
Treatment workstation (WLZZ-9999) instead of  behav-
ioral therapy completed by the patients and their sexual 
partners. The results showed that both PEDT and TCMS 
were effective for the treatment of  PPE, however the 
combined therapy is far more effective than the mono-
therapy. This study is only a preliminary exploration for 
the effect of  self-made TCMS as well as combined TCMS 
with PEDT, we just provided an idea for the develop-
ment of  new therapeutic agent for the treatment of  PPE, 
components in TCMS are complex and mechanism may 
be multifaceted, further research should be carried out to 
sieve the good from the bad and optimize the formula, 
deeply explore the mechanism of  action.
 
Conclusion                                
This study confirmed that the self-made TCMS was safe 
and effective, the combination of  TCMS and PEDT ther-
apy was more effective than the TCMS or PEDT mono-
therapy. However, components in TCMS are complex 
and mechanism may be multifaceted. Further research 
should be carried out to clarify the active ingredients in 
TCMS and their interaction.
 
Acknowledgments
The authors wish to thank the staff  members in phar-
macy department of  Enshi Tujia and Miao Autonomous 
Prefecture nationality Hospital who manufactured the 
TCMS, as well as the subjects who participated in this 
study.
Declaration of  conflicting interests
No competing financial interests exist.
 
References
1. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gin-
gell C, Moreira E, Wang T, Group GI. Sexual problems 
among women and men aged 40-80 y: prevalence and 
correlates identified in the Global Study of  Sexual At-
titudes and Behaviors. Int J Impot Res 2005; 17(1): 39-57.
2. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, 
Alexander J. The Premature Ejaculation Prevalence and 
Attitudes (PEPA) survey: prevalence, comorbidities, and 
professional help-seeking. Eur Urol 2007; 51(3): 816-823; 
discussion 824.
3. Rosen RC, Althof  S. Impact of  premature ejaculation: 
the psychological, quality of  life, and sexual relationship 
consequences. J Sex Med 2008; 5(6): 1296-1307.
4.  Rowland DL, Motofei IG. The aetiology of  premature 
ejaculation and the mind-body problem: implications for 
practice. Int J Clin Pract 2007; 61(1): 77-82.
5.  Xin ZC, Choi YD, Seong DH, Choi HK. Sensory 
evoked potential and effect of  SS-cream in premature 
ejaculation. Yonsei Med J 1995; 36(5): 397-401.
6. Xin ZC, Chung WS, Choi YD, Seong DH, Choi YJ, 
611 African Health Sciences Vol 17 Issue 3, September, 2017
Choi HK. Penile sensitivity in patients with primary pre-
mature ejaculation. J Urol 1996; 156(3): 979-981.
7.  Paick JS, Jeong H, Park MS. Penile sensitivity in men 
with premature ejaculation. Int J Impot Res 1998; 10(4): 
247-250.
8.  Zhang HF, Zhang CY, Li XH, Fu ZZ, Chen ZY. Dor-
sal penile nerves and primary premature ejaculation. Chin 
Med J (Engl) 2009; 122(24): 3017-3019.
9. Vignoli GC. Premature ejaculation: new electrophysio-
logic approach. Urology 1978; 11(1): 81-82.
10.  Xin ZC, Choi YD, Rha KH, Choi HK. Somatosenso-
ry evoked potentials in patients with primary premature 
ejaculation. J Urol 1997; 158(2): 451-455.
11. Adimoelja A. Phytochemicals and the breakthrough 
of  traditional herbs in the management of  sexual dys-
functions. Int J Androl 2000; 23 Suppl 2(82-84.
12.  Goswami SK, Pandre MK, Jamwal R, Dethe S, Agar-
wal A, Inamdar MN. Screening for Rho-kinase 2 inhib-
itory potential of  Indian medicinal plants used in man-
agement of  erectile dysfunction. J Ethnopharmacol 2012; 
144(3): 483-489.
13.  Hikino H, Ito T, Yamada C, Sato H. Analgesic prin-
ciples of  Aconitum roots. J Pharmacobiodyn 1979; 2(78-83.
14. Yamada K, Suzuki E, Nakaki T, Watanabe S, Kanba S. 
Aconiti tuber increases plasma nitrite and nitrate levels in 
humans. J Ethnopharmacol 2005; 96(1-2): 165-169.
15.  Jannini EA, McMahon C, Chen J, Aversa A, Perelman 
M. The controversial role of  phosphodiesterase type 5 
inhibitors in the treatment of  premature ejaculation. J Sex 
Med 2011; 8(8): 2135-2143.
16. Courtois F, Carrier S, Charvier K, Guertin PA, Journel 
NM. The control of  male sexual responses. Curr Pharm 
Des 2013; 19(24): 4341-4356.
17. Zhou RH. Resource Science of  Chinese Medicinal 
Materials. Resource Science of  Chinese Medicinal Mate-
rials press, Beijing 1993: pp. 202–211.
18. Zhang MF.  Chinese prickly ash temperature and ra-
tionale pharmacological effects. Northwest Pharm 1995; 
10(2):89-91.
19. Perelman MA. A new combination treatment for pre-
mature ejaculation: a sex therapist's perspective. J Sex Med 
2006; 3(6): 1004-1012.
20.  Gurkan L, Oommen M, Hellstrom WJ. Premature 
ejaculation: current and future treatments. Asian J Androl 
2008; 10(1): 102-109.
21. Dinsmore WW, Hackett G, Goldmeier D, Waldinger 
M, Dean J, Wright P, Callander M, Wylie K, Novak C, 
Keywood C, Heath P, Wyllie M. Topical eutectic mixture 
for premature ejaculation (TEMPE): a novel aerosol-de-
livery form of  lidocaine-prilocaine for treating premature 
ejaculation. BJU Int 2007; 99(2): 369-375.
22. Kockott G. Human sexual inadequacy--behavior ther-
apy and the Masters and Johnson technique. Adv Biosci 
1973; 10(219-224.
23. Waldinger MD. Premature ejaculation: state of  the art. 
Urol Clin North Am 2007; 34(4): 591-599, vii-viii.
24. Chen Guo hong, Song Shuqi, Yaqiang Z. A Clinical 
Study on Psycho Behavior Therapy for Premature Ejac-
ulation. Zhonghua N an Ke Xue Za Zh i 2009; 10(929 
- 931.
25. DSM-IV-TR. Diagnostic and statistical manual of  
mental disorders, fourth edition, text revision. Washing-
ton, DC: American Psychiatric Association, 2000.
26.  Patrick DL, Althof  SE, Pryor JL, Rosen R, Rowland 
DL, Ho KF, McNulty P, Rothman M, Jamieson C. Prema-
ture ejaculation: an observational study of  men and their 
partners. J Sex Med 2005; 2(3): 358-367.
27. Safarinejad MR, Hosseini SY. Safety and efficacy of  
tramadol in the treatment of  premature ejaculation: a 
double-blind, placebo-controlled, fixed-dose, random-
ized study. J Clin Psychopharmacol 2006; 26(1): 27-31.
28. Salem EA, Wilson SK, Bissada NK, Delk JR, Hell-
strom WJ, Cleves MA. Tramadol HCL has promise in 
on-demand use to treat premature ejaculation. J Sex Med 
2008; 5(1): 188-193.
29. Yuan YM, Xin ZC, Jiang H, Guo YJ, Liu WJ, Tian 
L, Zhu JC. Sexual function of  premature ejaculation pa-
tients assayed with Chinese Index of  Premature Ejacula-
tion. Asian J Androl 2004; 6(2): 121-126.
30.  Hatzimouratidis K, Amar E, Eardley I, Giuliano F, 
Hatzichristou D, Montorsi F, Vardi Y, Wespes E, Europe-
an Association of  U. Guidelines on male sexual dysfunc-
tion: erectile dysfunction and premature ejaculation. Eur 
Urol 2010; 57(5): 804-814.
31.  Choi HK, Jung GW, Moon KH, Xin ZC, Choi YD, 
Lee WH, Rha KH, Choi YJ, Kim DK. Clinical study of  
SS-cream in patients with lifelong premature ejaculation. 
Urology 2000; 55(2): 257-261.
32. Busato W, Galindo CC. Topical anaesthetic use for 
treating premature ejaculation: a double-blind, random-
ized, placebo-controlled study. BJU Int 2004; 93(7): 1018-
1021.
      612African Health Sciences Vol 17 Issue 3, September, 2017
33.  Mitamura M, Boussery K, Horie S, Murayama T, Van 
de Voorde J. Vasorelaxing effect of  mesaconitine, an al-
kaloid from Aconitum japonicum, on rat small gastric artery: 
possible involvement of  endothelium-derived hyperpo-
larizing factor. Jpn J Pharmacol 2002; 89(4): 380-387.
34.  Shu H, Arita H, Hayashida M, Sekiyama H, Hanaoka 
K. Effects of  processed Aconiti tuber and its ingredient 
alkaloids on the development of  antinociceptive toler-
ance to morphine. J Ethnopharmacol 2006; 103(3): 398-405.
35.  Wang XL, Jin LJ, Xu FX, Xu YP, Li XY.Rearch prog-
ress of  Chinese herb-Asarum. Asia-Pacific Traditioal Medi-
cine 2013; 9(7): 68-71.  
36.  Zheng J, Zhang L. Research progress of  Pericarpium 
Zanthoxyli in medical use. Journal of  Liaoning University of  
TCM 2008; 10(69-70.
37.   Mishra RK, Singh SK. Reproductive effects of  lipid 
soluble components of  Syzygium aromaticum flower bud in 
male mice. J Ayurveda Integr Med 2013; 4(2): 94-98.
38. Lorenz MM, Alkhafadji L, Stringano E, Nilsson S, 
Mueller-Harvey I, Uden P. Relationship between con-
densed tannin structures and their ability to precipitate 
feed proteins in the rumen. J Sci Food Agric 2013; 10.1002/
jsfa.6344.
39.  Dinsmore WW, Wyllie MG. PSD502 improves ejac-
ulatory latency, control and sexual satisfaction when 
applied topically 5 min before intercourse in men with 
premature ejaculation: results of  a phase III, multicentre, 
double-blind, placebo-controlled study. BJU Int 2009; 
103(7): 940-949.
40.  Carson C, Wyllie M. Improved ejaculatory latency, 
control and sexual satisfaction when PSD502 is applied 
topically in men with premature ejaculation: results of  a 
phase III, double-blind, placebo-controlled study. J Sex 
Med 2010; 7(9): 3179-3189.
613 African Health Sciences Vol 17 Issue 3, September, 2017
